Orlistat 60 mg vs Customized Polyglucosamine for Overweight and Obesity Management
This study aims to compare the effectiveness of Orlistat 60 mg and customized Polyglucosamine in helping overweight and obese individuals achieve a weight reduction of 5% or more from their initial weight.
orlistat 60 mg
+ polyglucosamine
Body Weight+7
+ Body Weight Changes
+ Nutrition Disorders
Prevention Study
Summary
Study start date: November 1, 2009
Actual date on which the first participant was enrolled.A study is comparing two treatments for overweight and obesity management: Orlistat 60 mg and customized Polyglucosamine. Orlistat is a capsule taken three times a day, while Polyglucosamine is a tablet taken twice daily with the two main meals containing the highest fat content. Both treatments aim to aid weight loss in overweight adults, with Orlistat used alongside a reduced-calorie and low-fat diet. The purpose of this research is to find an effective prevention method for overweight and obesity, addressing a significant health challenge. Participants in this study will be divided into two groups, each receiving one of the two treatments. The primary outcome measured is the number of participants in both groups who achieve a weight reduction of 5 percent or more compared to their initial weight. This comparison helps determine the effectiveness of each treatment method in managing overweight and obesity.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.64 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 21 to 70 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 2 locations
MAP Center
Rende, Italy